AstraZeneca turns to AI for cancer antibody research
AstraZeneca is teaming up with Absci for AI-driven cancer antibody research, promising to reshape oncology treatments through generative AI and synthetic biology collaboration.
Latest Absci News
AstraZeneca is teaming up with Absci for AI-driven cancer antibody research, promising to reshape oncology treatments through generative AI and synthetic biology collaboration.